716 related items for PubMed ID: 15688664
1. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[Abstract] [Full Text] [Related]
2. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[Abstract] [Full Text] [Related]
3. [Fluticasone propionate in children and infants with asthma].
Marchac V, Foussier V, Devillier P, Le Bourgeois M, Polak M.
Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
[Abstract] [Full Text] [Related]
4. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
[Abstract] [Full Text] [Related]
5. Clinical aspects of anti-inflammatory therapy in asthma.
Kumar A, Busse WW.
Curr Opin Pulm Med; 1996 Jan; 2(1):40-7. PubMed ID: 9363114
[Abstract] [Full Text] [Related]
6. Inhaled corticosteroids: clinical relevance of safety measures.
Price JF.
Pediatr Pulmonol Suppl; 1997 Sep; 15():40-5. PubMed ID: 9316101
[Abstract] [Full Text] [Related]
7. A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma.
Iles R, Williams RM, Deeb A, Ross-Russell R, Acerini CL.
Pediatr Pulmonol; 2008 Apr; 43(4):354-9. PubMed ID: 18286548
[Abstract] [Full Text] [Related]
8. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
Cetinkaya F, Kayiran P, Memioglu N, Tarim OF, Eren N, Erdem E.
Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
[Abstract] [Full Text] [Related]
9. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P, Shah M, Muley A.
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[Abstract] [Full Text] [Related]
10. [Report of a case. Inhalation steroids caused adrenal cortex suppression].
Rask E, Eriksson JW, Forsberg G.
Lakartidningen; 1997 Oct 01; 94(40):3529-30, 3533. PubMed ID: 9411094
[Abstract] [Full Text] [Related]
11. Fluticasone propionate in children with moderate asthma.
Hoekstra MO, Grol MH, Bouman K, Stijnen T, Köeter GH, Kauffman HF, Gerritsen J.
Am J Respir Crit Care Med; 1996 Oct 01; 154(4 Pt 1):1039-44. PubMed ID: 8887604
[Abstract] [Full Text] [Related]
12. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P, Berar-Yanay N, Davidovich A, Magadle R.
Chest; 1999 Oct 01; 116(4):931-4. PubMed ID: 10531155
[Abstract] [Full Text] [Related]
13. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
J Allergy Clin Immunol; 1998 Jul 01; 102(1):32-8. PubMed ID: 9679845
[Abstract] [Full Text] [Related]
14. Adrenal suppression secondary to inhaled fluticasone propionate.
Taylor AV, Laoprasert N, Zimmerman D, Sachs MI.
Ann Allergy Asthma Immunol; 1999 Jul 01; 83(1):68-70. PubMed ID: 10437819
[Abstract] [Full Text] [Related]
15. [Adrenal cortex function in children with bronchial asthma in fluticasone therapy].
Hoffmann-Streb A, L'Allemand D, Niggemann B, Büttner P, Wahn U.
Monatsschr Kinderheilkd; 1993 Jun 01; 141(6):508-12. PubMed ID: 8336748
[Abstract] [Full Text] [Related]
16. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Nielsen LP, Dahl R.
Am J Respir Crit Care Med; 2000 Jun 01; 161(6):2114-5. PubMed ID: 10852798
[No Abstract] [Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
Zöllner EW, Lombard CJ, Galal U, Hough FS, Irusen EM, Weinberg E.
Pediatrics; 2012 Dec 01; 130(6):e1512-9. PubMed ID: 23147980
[Abstract] [Full Text] [Related]
18. Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma.
Griffiths AL, Sim D, Strauss B, Rodda C, Armstrong D, Freezer N.
Pediatr Pulmonol; 2004 Feb 01; 37(2):116-21. PubMed ID: 14730656
[Abstract] [Full Text] [Related]
19. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
Kannisto S, Korppi M, Remes K, Voutilainen R.
J Clin Endocrinol Metab; 2000 Feb 01; 85(2):652-7. PubMed ID: 10690871
[Abstract] [Full Text] [Related]
20. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
Chest; 2005 Sep 01; 128(3):1104-14. PubMed ID: 16162694
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
